SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether investor losses may be recovered under federal securities laws.
What if I purchased Fulgent securities?
If you purchased Fulgent securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.
There is no cost or obligation to you.
Background of the investigation
On February 27, 2026, Fulgent reported its fourth quarter and full year 2025 financial results. The Company disclosed that full year 2025 revenue was approximately $322.7 million, which fell slightly short of the updated guidance previously provided. Fulgent also reported that fourth quarter revenue declined sequentially.
During the earnings call, management stated that the decrease in fourth quarter revenue was primarily the result of lower-than-anticipated volume from the Company’s largest customer, which had begun transitioning testing in-house. The Company further disclosed that this customer accounted for approximately 22% of total revenue in 2025 and that revenue in the first half of 2026 is expected to be impacted by a significant decrease in volume related to this transition.
Following this disclosure, Fulgent’s shares declined as investors reacted to the revenue miss, customer concentration impact, and updated outlook.
In light of this disclosure, Johnson Fistel is investigating whether Fulgent complied with the federal securities laws. If you suffered losses from your investment in Fulgent stock, contact Johnson Fistel.
About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.
Achievements
In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. This recognition reflects the firm’s effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where it served as lead or co-lead counsel. This marks the eighth time the firm has been recognized as a top plaintiffs’ securities law firm in the United States, based on the total dollar value of final recoveries.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com
